MedTrace Logo

Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments

NCT03821103 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2020-03-17

No results posted yet for this study

Summary

This study seeks to test standard and behavioral economic-enhanced training strategies to bolster first-time Emergency Department-initiated buprenorphine-naloxone administration among Emergency Department providers.

Conditions

  • Opioid Use

Interventions

BEHAVIORAL

Training

The training includes of (1) in-person training with pre- and post-session knowledge and attitude assessment, (2) three month post-session knowledge and attitude assessment and (3) self-report of first-time buprenorphine-naloxone Emergency Department (ED) administration within 3 month study period

BEHAVIORAL

Behavioral economic enhanced arm

Behavioral economic enhancement includes an opt-out invitation, loss-framed incentivization, weekly tailored text based reminders

Sponsors & Collaborators

  • American College of Medical Toxicology

    collaborator OTHER

  • Blue Cross Blue Shield

    collaborator OTHER

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Jeanmarie Perrone, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-06
Primary Completion
2020-01-31
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03821103 on ClinicalTrials.gov